Quarterly Results

Q3 2023
STANDEX REPORTS FISCAL THIRD QUARTER 2023 FINANCIAL RESULTS
  • Record Adjusted Operating Margin of 15.2%, up 140 bps year-on-year; Eighth Consecutive Quarter of Record Level Adjusted Operating Margin
  • GAAP Operating Margin of 48.0% Driven by Gain on Procon Divestiture
  • Fast Growth Market Sales Increased ~40% year-on-year to ~$23 million; Fast Growth Market Sales in Fiscal 2023 Expected to Increase ~50% to ~$85 million
  • Expect Organic Revenue Growth in Fiscal Year 2023 from Four of Five Business Segments
  • Generated $17.6 million in Free Cash Flow

SALEM, N.H., May 4, 2023 /PRNewswire/ -- Standex International Corporation (NYSE: SXI) today reported financial results for the third quarter of fiscal year 2023 ended March 31, 2023.

 Summary Financial Results - Total Standex

         

($M except EPS and Dividends)

3Q23

3Q22

2Q23

Y/Y

Q/Q

Net Sales

$184.3

$189.3

$187.8

-2.6 %

-1.8 %

Operating Income - GAAP

$88.5

$24.5

$27.8

261.7 %

218.3 %

Operating Income - Adjusted

$27.9

$26.1

$28.6

7.0 %

-2.3 %

Operating Margin % - GAAP

48.0 %

12.9 %

14.8 %

+ 3510 bps

+ 3320 bps

Operating Margin % - Adjusted

15.2 %

13.8 %

15.2 %

+ 140 bps

+ 0 bps

Net Income from Continuing Ops - GAAP

$80.6

$17.4

$20.1

362.8 %

301.2 %

Net Income from Continuing Ops - Adjusted

$19.6

$18.7

$20.7

5.2 %

-5.2 %

           

EBITDA

$95.1

$31.3

$34.8

203.6 %

172.9 %

EBITDA margin

51.6 %

16.5 %

18.5 %

 + 3510 bps

+ 3310 bps

Adjusted EBITDA

$34.5

$33.0

$35.6

4.7 %

-3.2 %

Adjusted EBITDA margin

18.7 %

17.4 %

19.0 %

+ 130 bps

 -30 bps

           

Diluted EPS - GAAP

$6.77

$1.43

$1.69

370.1 %

300.6 %

Diluted EPS - Adjusted

$1.65

$1.54

$1.74

7.1 %

-5.2 %

Dividends per Share

$0.28

$0.26

$0.28

7.7 %

0.0 %

           

Free Cash Flow

$17.6

$8.5

$24.0

107.3 %

-26.6 %

Net Debt to EBITDA

0.0x

0.5x

0.6x

NM

NM

 

Third Quarter Fiscal 2023 Results 

Commenting on the quarter's results, President and Chief Executive Officer David Dunbar said, "Our third fiscal quarter results demonstrate our businesses' ability to perform well in an uncertain macro environment. On the top line, we delivered 1.5% organic growth, offset by foreign currency exchange and the divestiture of our Procon business unit. Sales from fast growth markets such as electric vehicles, renewable energy, smart grid, and the commercialization of space increased approximately 40% year on year to $23 million in fiscal third quarter 2023, and we anticipate our fast growth market sales for fiscal year 2023 to increase approximately 50% versus prior year. We achieved record gross margin of 38.5%, up 240 bps year on year and record consolidated adjusted operating margin of 15.2% in fiscal third quarter 2023 - our eighth consecutive quarter of record level adjusted operating margin performance. This margin growth reflects the benefits of our customer intimacy model and solid execution of our pricing and productivity initiatives.

"We remain confident in our ability to navigate this environment and continue to deliver improved results. Our regional presence, strong customer relationships and our disciplined approach to pricing and productivity have protected us from the challenges presented by supply chain challenges and inflation. We continue to benefit from secular trends in our fast growth markets, which are still in the early stages of evolution. As a result, we expect all our segments, except Scientific, to contribute to organic growth for the fiscal year."

"In addition, Standex's consistent cash generation and substantial financial flexibility continue to position us well to pursue an active pipeline of organic and inorganic growth opportunities. Our free cash flow conversion remained healthy at near 100% in the fiscal third quarter. We have approximately $344 million in available liquidity."

Outlook

In fiscal fourth quarter 2023, on a sequential basis, the Company expects similar revenue with organic sales growth offsetting the impact of the Procon divestiture. The Company expects similar to slightly higher adjusted operating margin. On a year-on-year basis, the Company expects mid to high single digit organic growth offset by the Procon divestiture and significant adjusted operating margin improvement due to continued realization of pricing and productivity initiatives.

Third Quarter Segment Operating Performance

Electronics (42% of sales; 47% of segment operating income)

 

3Q23

3Q22

% Change

Electronics ($M)

     

Revenue

78.2

79.9

-2.1 %

GAAP Operating Income

17.0

19.2

-11.2 %

GAAP Operating Margin %

21.8

24.0

 

Adjusted Operating Income*

17.0

19.2

-11.3 %

Adjusted Operating Margin %*

21.8

24.1

 

*3Q22 excludes less than $0.1M of purchase accounting expenses associated with Sensor Solutions

Revenue decreased approximately $1.7 million or 2.1% year-on-year reflecting organic growth of 1.3%, more than offset by a 3.4% impact from foreign exchange. The segment is seeing positive trends in end markets like industrial applications, power management, renewable energy technologies, and EV-related applications.

Electronics segment backlog realizable in under one year of approximately $145 million decreased 4% year-on-year. The segment had a book to bill ratio of 0.92 at the end of the fiscal third quarter.

Adjusted operating income decreased approximately $2.2 million or 11.3% year-on-year due to lower sales and product mix, partially offset by pricing and productivity initiatives.

In fiscal fourth quarter 2023, on a sequential basis, the Company expects similar revenue and operating margin primarily due to increased sales into fast growth markets, offset by a slower recovery in China and Europe.

Engraving (20% of sales; 15% of segment operating income)

 

3Q23

3Q22

% Change

Engraving ($M)

     

Revenue

36.9

37.2

-0.8 %

Operating Income

5.4

5.7

-6.5 %

Operating Margin %

14.5

15.4

 

           

Revenue decreased approximately $0.3 million or 0.8% year-on-year reflecting 3.9% organic growth, which was more than offset by a 4.7% impact from foreign exchange. Operating income decreased $0.4 million or 6.5% year-on-year, primarily driven by unfavorable regional mix. The segment had a book to bill ratio of 1.12, indicating continued end market stability.

In fiscal fourth quarter 2023, on a sequential basis, the Company expects similar to slightly higher revenue and operating margin.

Scientific (10% of sales; 13% of segment operating income)

 

3Q23

3Q22

% Change

Scientific ($M)

     

Revenue

18.9

18.9

-0.1 %

Operating Income

4.6

4.2

9.8 %

Operating Margin %

24.1

22.0

 

 

Revenue remained flat at $18.9 million reflecting higher sales into research and academic end markets, offset by lower demand for COVID vaccine storage units. Operating income increased approximately $0.4 million or 9.8% year-on-year due to price and productivity actions and lower freight cost.

In fiscal fourth quarter 2023, on a sequential basis, the Company expects similar revenue and slightly higher operating margin.

Engineering Technologies (10% of sales; 7% of segment operating income)

 

3Q23

3Q22

% Change

Engineering Technologies ($M)

     

Revenue

18.1

20.9

-13.6 %

Operating Income

2.4

2.3

1.0 %

Operating Margin %

13.0

11.1

 

 

Revenue decreased approximately $2.8 million or 13.6% year-on-year reflecting lower volume due to the timing of projects, partially offset by higher revenue from new product development. Operating income remained flat at approximately $2.4 million reflecting the impact of productivity and efficiency initiatives offsetting the lower volume.

In fiscal fourth quarter 2023, on a sequential basis, the Company expects a moderate increase in revenue and operating margin, reflecting more favorable timing of projects in aviation and space end markets.

Specialty Solutions (18% of sales; 18% of segment operating income)

 

3Q23

3Q22

% Change

Specialty Solutions ($M)

     

Revenue

32.3

32.4

-0.3 %

Operating Income

7.2

3.6

96.9 %

Operating Margin %

22.2

11.2

 

 

Specialty Solutions revenue remained relatively flat at $32.3 million, reflecting robust organic growth in the Display Merchandising business, offset by an organic decline in the Hydraulics business and the Procon divestiture. Operating income increased approximately $3.5 million or 96.9% year-on-year driven by higher sales in the Display Merchandising business and realization of productivity initiatives in the Hydraulics business.

In fiscal fourth quarter 2023, on a sequential basis, the Company expects a moderate to significant decline in revenue primarily due to the Procon divestiture and lower sales in the Display Merchandising business and slightly lower operating margin.

Capital Allocation

  • Share Repurchase: During the fiscal third quarter, the Company repurchased approximately 42,500 shares for $5.0 million. There was $72.1 million remaining on the Company's current share repurchase authorization at the end of the fiscal third quarter 2023.  
  • Capital Expenditures: In fiscal third quarter 2023, Standex's capital expenditures were $5.6 million compared to $3.4 million in the fiscal third quarter of 2022. The Company expects fiscal year 2023 capital expenditures between $25 million and $30 million with key investments focused on growth initiatives and capacity expansion. Capital expenditures were $23.9 million in fiscal 2022.
  • Dividend: On April 27, 2023, the Company declared a quarterly cash dividend of $0.28 per share, an approximately 7.7% year-on-year increase. The dividend is payable May 25, 2023, to shareholders of record on May 10, 2023.

Balance Sheet and Cash Flow Highlights

  • Net Debt: Standex had net (cash) debt of ($2.0) million on March 31, 2023, compared to $70.0 million at the end of fiscal 2022 and $65.8 million at the end of fiscal third quarter 2022. Net debt for the third quarter of 2023 consisted primarily of long-term debt of $173.3 million and cash and equivalents of $175.3 million.
  • Cash Flow: Net cash provided by continuing operating activities for the three months ended March 31, 2023, was $23.3 million compared to $11.9 million in the prior year's quarter. Free cash flow after capital expenditures was $17.6 million compared to free cash flow after capital expenditures of $8.5 million in the fiscal third quarter of 2022. 

Conference Call Details

Standex will host a conference call for investors tomorrow, May 5, 2023, at 8:30 a.m. ET. On the call, David Dunbar, President, and CEO, and Ademir Sarcevic, CFO, will review the Company's financial results and business and operating highlights. Investors interested in listening to the webcast and viewing the slide presentation should log on to the "Investors" section of Standex's website under the subheading, "Events and Presentations," located at www.standex.com.

A replay of the webcast will also be available on the Company's website shortly after the conclusion of the presentation online through May 5, 2024. To listen to the teleconference playback, please dial in the U.S. (877) 344-7529 or (412) 317-0088 internationally; the passcode is 7047258. The audio playback via phone will be available through May 12, 2023. The webcast replay can be accessed in the "Investor Relations" section of the Company's website, located at www.standex.com.

Use of Non-GAAP Financial Measures

In addition to the financial measures prepared in accordance with generally accepted accounting principles ("GAAP"), the Company uses certain non-GAAP financial measures, including non-GAAP adjusted income from operations, non-GAAP adjusted net income from continuing operations, free operating cash flow, EBITDA (earnings before interest, taxes, depreciation and amortization) adjusted EBITDA, adjusted EBITDA to net debt, and adjusted earnings per share. The attached financial tables reconcile non-GAAP measures used in this press release to the most directly comparable GAAP measures. The Company believes that the use of non-GAAP measures which include the impact of restructuring charges, purchase accounting, insurance recoveries, discrete tax events, gain or loss on sale of a business unit, acquisition costs, and litigation costs help investors to obtain a better understanding of our operating results and prospects, consistent with how management measures and forecasts the Company's performance, especially when comparing such results to previous periods.  An understanding of the impact in a particular quarter of specific restructuring costs, acquisition expenses, or other gains and losses, on net income (absolute as well as on a per-share basis), operating income or EBITDA can give management and investors additional insight into core financial performance, especially when compared to quarters in which such items had a greater or lesser effect, or no effect.  Non-GAAP measures should be considered in addition to, and not as a replacement for, the corresponding GAAP measures, and may not be comparable to similarly titled measures reported by other companies.

About Standex

Standex International Corporation is a multi-industry manufacturer in five broad business segments: Electronics, Engraving, Scientific, Engineering Technologies, and Specialty Solutions with operations in the United States, Europe, Canada, Japan, Singapore, Mexico, Brazil, Turkey, South Africa, India, and China. For additional information, visit the Company's website at http://standex.com/.

Forward-Looking Statements

Statements contained in this Press Release that are not based on historical facts are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by the use of forward-looking terminology such as "should," "could," "may," "will," "expect," "believe," "estimate," "anticipate," "intend," "continue," or similar terms or variations of those terms or the negative of those terms. There are many factors that affect the Company's business and the results of its operations and that may cause the actual results of operations in future periods to differ materially from those currently expected or anticipated. These factors include, but are not limited to: the impact of pandemics such as the current coronavirus on employees, our supply chain, and the demand for our products and services around the world; materially adverse or unanticipated legal judgments, fines, penalties or settlements; conditions in the financial and banking markets, including fluctuations in exchange rates and the inability to repatriate foreign cash; domestic and international economic conditions, including the impact, length and degree of economic downturns on the customers and markets we serve and more specifically conditions in the automotive, construction, aerospace, defense, transportation, food service equipment, consumer appliance, energy, oil and gas and general industrial markets; lower-cost competition; the relative mix of products which impact margins and operating efficiencies in certain of our businesses; the impact of higher raw material and component costs, particularly steel, certain materials used in electronics parts, petroleum based products, and refrigeration components; the impact of higher transportation and logistics costs, especially with respect to transportation of goods from Asia; the impact of inflation on the costs of providing our products and services; an inability to realize the expected cost savings from restructuring activities including effective completion of plant consolidations, cost reduction efforts including procurement savings and productivity enhancements, capital management improvements, strategic capital expenditures, and the implementation of lean enterprise manufacturing techniques; the potential for losses associated with the exit from or divestiture of businesses that are no longer strategic or no longer meet our growth and return expectations; the inability to achieve the savings expected from global sourcing of raw materials and diversification efforts in emerging markets; the impact on cost structure and on economic conditions as a result of actual and threatened increases in trade tariffs; the inability to attain expected benefits from acquisitions and the inability to effectively consummate and integrate such acquisitions and achieve synergies envisioned by the Company; market acceptance of our products; our ability to design, introduce and sell new products and related product components; the ability to redesign certain of our products to continue meeting evolving regulatory requirements; the impact of delays initiated by our customers; our ability to increase manufacturing production to meet demand including as a result of labor shortages; and potential changes to future pension funding requirements. In addition, any forward-looking statements represent management's estimates only as of the day made and should not be relied upon as representing management's estimates as of any subsequent date. While the Company may elect to update forward-looking statements at some point in the future, the Company and management specifically disclaim any obligation to do so, even if management's estimates change.

 

Standex International Corporation

Consolidated Statement of Operations

     

(unaudited)

                 
                         
     

Three Months Ended

   

Nine Months Ended

     

March 31,

   

March 31,

(In thousands, except per share data)

   

2023

   

2022

   

2023

   

2022

                         

Net sales

 

$

184,332

   

189,281

 

$

552,721

 

$

550,600

Cost of sales

   

113,435

   

120,900

   

341,251

   

347,210

Gross profit

   

70,897

   

68,381

   

211,470

   

203,390

                         

Selling, general and administrative expenses

   

42,954

   

42,306

   

127,756

   

128,589

(Gain) loss on sale of business

   

(62,105)

   

-

   

(62,105)

   

-

Restructuring costs

   

2,237

   

1,186

   

3,330

   

2,469

Acquisition related costs

   

21

   

419

   

487

   

1,561

Other operating (income) expense, net

   

(727)

   

-

   

(611)

   

1,700

                         

Income from operations

   

88,517

   

24,470

   

142,613

   

69,071

                         

Interest expense

   

1,415

   

1,238

   

4,168

   

4,484

Other non-operating (income) expense, net

   

747

   

340

   

1,695

   

651

Total

   

2,162

   

1,578

   

5,863

   

5,135

                         

Income from continuing operations before income taxes

   

86,355

   

22,892

   

136,750

   

63,936

Provision for income taxes

   

5,788

   

5,484

   

17,783

   

15,677

Net income from continuing operations

   

80,567

   

17,408

   

118,967

   

48,259

                         

Income (loss) from discontinued operations, net of tax

   

(57)

   

(86)

   

(144)

   

(135)

                         

Net income

 

$

80,510

 

$

17,322

 

$

118,823

 

$

48,124

                         

Basic earnings per share:

                       

Income (loss) from continuing operations

 

$

6.82

 

$

1.45

 

$

10.06

 

$

4.02

Income (loss) from discontinued operations

   

-

   

(0.01)

   

(0.01)

   

(0.01)

Total

 

$

6.82

 

$

1.44

 

$

10.05

 

$

4.01

                         

Diluted earnings per share:

                       

Income (loss) from continuing operations

 

$

6.77

 

$

1.44

 

$

9.98

 

$

3.98

Income (loss) from discontinued operations

   

-

   

(0.01)

   

(0.01)

   

(0.01)

Total

 

$

6.77

 

$

1.43

 

$

9.97

 

$

3.97

                         

Average Shares Outstanding

                       

   Basic

   

11,811

   

11,982

   

11,825

   

12,009

   Diluted

   

11,895

   

12,089

   

11,917

   

12,121

                         

 

Standex International Corporation

Condensed Consolidated Balance Sheets

(unaudited)

             
     

March 31,

   

June 30,

(In thousands)

   

2023

   

2022

             

ASSETS

           

Current assets:

           

  Cash and cash equivalents

 

$

175,284

 

$

104,844

  Accounts receivable, net

   

121,161

   

117,075

  Inventories

   

104,516

   

105,339

  Prepaid expenses and other current assets

   

56,611

   

45,210

  Income taxes receivable

   

3,203

   

6,530

    Total current assets

   

460,775

   

378,998

             

Property, plant, equipment, net

   

130,638

   

128,584

Intangible assets, net

   

79,562

   

85,770

Goodwill

   

269,463

   

267,906

Deferred tax asset

   

9,213

   

8,186

Operating lease right-of-use asset

   

36,069

   

39,119

Other non-current assets

   

29,368

   

25,876

    Total non-current assets

   

554,313

   

555,441

             

Total assets

 

$

1,015,088

 

$

934,439

             

LIABILITIES AND STOCKHOLDERS' EQUITY

         
             

Current liabilities:

           

  Accounts payable

 

$

67,512

 

$

74,520

  Accrued liabilities

   

55,704

   

67,773

  Income taxes payable

   

7,371

   

8,475

    Total current liabilities

   

130,587

   

150,768

             

Long-term debt

   

173,333

   

174,830

Operating lease long-term liabilities

   

28,463

   

31,357

Accrued pension and other non-current liabilities

   

77,155

   

78,141

    Total non-current liabilities

   

278,951

   

284,328

             

Stockholders' equity:

           

  Common stock

   

41,976

   

41,976

  Additional paid-in capital

   

97,294

   

91,200

  Retained earnings

   

1,010,395

   

901,421

  Accumulated other comprehensive loss

   

(147,175)

   

(153,312)

  Treasury shares

   

(396,940)

   

(381,942)

     Total stockholders' equity

   

605,550

   

499,343

             

Total liabilities and stockholders' equity

 

$

1,015,088

 

$

934,439

             

 

Standex International Corporation and Subsidiaries

       

Statements of Consolidated Cash Flows

       

(unaudited)

       
     

Nine Months Ended

     

March 31,

(In thousands)

   

2023

   

2022

             

Cash Flows from Operating Activities

           

Net income

 

$

118,823

 

$

48,124

Income (loss) from discontinued operations

   

(144)

   

(135)

Income from continuing operations

   

118,967

   

48,259

             

Adjustments to reconcile net income to net cash provided by operating activities:

           

Depreciation and amortization

   

21,275

   

22,411

Stock-based compensation

   

8,508

   

8,213

Non-cash portion of restructuring charge

   

129

   

595

(Gain) loss on sale of business

   

(62,105)

   

-

Contributions to defined benefit plans

   

(151)

   

(157)

Net changes in operating assets and liabilities

   

(36,268)

   

(30,693)

Net cash provided by operating activities - continuing operations

   

50,355

   

48,628

Net cash provided by (used in) operating activities - discontinued operations

   

(37)

   

(364)

Net cash provided by (used in) operating activities

   

50,318

   

36,335

Cash Flows from Investing Activities

           

    Expenditures for property, plant and equipment

   

(16,648)

   

(13,138)

    Expenditures for acquisitions, net of cash acquired

   

-

   

(9,902)

    Proceeds from the sale of business

   

67,023

   

-

    Other investing activities

   

(1,321)

   

5,718

Net cash (used in) investing activities

   

49,054

   

(17,322)

Cash Flows from Financing Activities

           

    Proceeds from borrowings

   

224,500

   

-

    Payments of debt

   

(226,200)

   

-

    Contingent consideration payment

   

(1,167)

   

(1,167)

    Activity under share-based payment plans

   

1,170

   

1,318

    Purchase of treasury stock

   

(18,582)

   

(21,420)

    Cash dividends paid

   

(9,699)

   

(9,148)

    Other financing activities

           

Net cash provided by (used in) financing activities from continuing operations

   

(29,978)

   

(30,417)

Net cash provided by financing activities from discontinued operations

   

-

   

-

Net cash provided by (used in) financing activities

   

(29,978)

   

(30,417)

             

Effect of exchange rate changes on cash

   

1,046

   

(2,979)

             

Net changes in cash and cash equivalents

   

70,440

   

(2,465)

Cash and cash equivalents at beginning of year

   

104,844

   

136,367

Cash and cash equivalents at end of period

 

$

175,284

 

$

133,902

             

 

Standex International Corporation

Selected Segment Data

(unaudited)

                         
     

Three Months Ended

   

Nine Months Ended

     

March 31,

   

March 31,

(In thousands)

   

2023

   

2022

   

2023

   

2022

Net Sales

                       

Electronics

 

$

78,211

 

$

79,889

 

$

225,966

 

$

232,351

Engraving

   

36,909

   

37,223

   

109,622

   

109,037

Scientific

   

18,898

   

18,914

   

56,646

   

65,079

Engineering Technologies

   

18,052

   

20,890

   

59,244

   

56,558

Specialty Solutions

   

32,262

   

32,365

   

101,243

   

87,575

Total

 

$

184,332

 

$

189,281

 

$

552,721

 

$

550,600

                         

Income from operations

                       

Electronics

 

$

17,047

 

$

19,194

 

$

52,160

 

$

54,624

Engraving

   

5,353

   

5,728

   

17,580

   

15,806

Scientific

   

4,561

   

4,155

   

12,449

   

14,153

Engineering Technologies

   

2,351

   

2,327

   

7,957

   

5,540

Specialty Solutions

   

7,151

   

3,632

   

18,944

   

10,185

Restructuring

   

(2,237)

   

(1,186)

   

(3,330)

   

(2,469)

(Gain) loss on sale of business

   

62,105

   

-

   

62,105

   

-

Acquisition related costs

   

(21)

   

(419)

   

(487)

   

(1,561)

Corporate

   

(8,520)

   

(8,961)

   

(25,376)

   

(25,507)

Other operating income (expense), net 

   

727

   

-

   

611

   

(1,700)

Total

 

$

88,517

 

$

24,470

 

$

142,613

 

$

69,071

                         

 

Standex International Corporation

   

Reconciliation of GAAP to Non-GAAP Financial Measures

   

(unaudited)

   
                                   
       

Three Months Ended

       

Nine Months Ended

   
       

March 31,

       

March 31,

   

(In thousands, except percentages)

   

2023

   

2022

 

% Change

   

2023

   

2022

 

% Change

Adjusted income from operations and adjusted net
income from continuing operations:

                               

Net Sales

 

$

184,332

 

$

189,281

 

-2.6 %

 

$

552,721

 

$

550,600

 

0.4 %

Income from operations, as reported

 

$

88,517

 

$

24,470

 

261.7 %

 

$

142,613

 

$

69,071

 

106.5 %

 

Income from operations margin

   

48.0 %

   

12.9 %

       

25.8 %

   

12.5 %

   

Adjustments:

                               
 

Restructuring charges

   

2,237

   

1,186

       

3,330

   

2,469

   
 

Acquisition-related costs

   

21

   

419

       

487

   

1,561

   
 

Litigation (settlement refund) charge

   

(996)

   

-

       

(881)

   

1,700

   
 

(Gain) loss on sale of business

   

(62,105)

   

-

       

(62,105)

   

-

   
 

Environmental remediation

   

271

   

-

       

271

   

-

   
 

Purchase accounting expenses

   

-

   

31

       

-

   

31

   

Adjusted income from operations

 

$

27,945

 

$

26,106

 

7.0 %

 

$

83,715

 

$

74,832

 

11.9 %

 

Adjusted income from operations margin

   

15.2 %

   

13.8 %

       

15.1 %

   

13.6 %

   
 

Interest and other income (expense), net

   

(2,162)

   

(1,578)

       

(5,863)

   

(5,135)

   
 

Provision for income taxes

   

(5,788)

   

(5,484)

       

(17,783)

   

(15,677)

   
 

Discrete and other tax items

   

-

   

-

       

100

   

-

   
 

Tax impact of above adjustments

   

(370)

   

(392)

       

(769)

   

(1,413)

   

Net income from continuing operations, as adjusted

 

$

19,625

 

$

18,652

 

5.2 %

 

$

59,400

 

$

52,607

 

12.9 %

                                   

EBITDA and Adjusted EBITDA:

                               

Net income (loss) from continuing operations, as reported

 

$

80,567

 

$

17,408

 

362.8 %

 

$

118,967

 

$

48,259

   
 

Net income from continuing operations margin

   

43.7 %

   

9.2 %

       

21.5 %

   

8.8 %

   

Add back:

                               
 

Provision for income taxes

   

5,788

   

5,484

       

17,783

   

15,677

   
 

Interest expense

   

1,415

   

1,238

       

4,168

   

4,484

   
 

Depreciation and amortization

   

7,309

   

7,189

       

21,275

   

22,411

   

EBITDA

 

$

95,079

 

$

31,319

 

203.6 %

 

$

162,193

 

$

90,831

 

78.6 %

 

EBITDA Margin

   

51.6 %

   

16.5 %

       

29.3 %

   

16.5 %

   

Adjustments:

                               
 

Restructuring charges

   

2,237

   

1,186

       

3,330

   

2,469

   
 

Acquisition-related costs

   

21

   

419

       

487

   

1,561

   
 

Litigation (settlement refund) charge

   

(996)

   

-

       

(881)

   

1,700

   
 

(Gain) loss on sale of business

   

(62,105)

   

-

       

(62,105)

   

-

   
 

Environmental remediation

   

271

   

-

       

271

   

-

   
 

Purchase accounting expenses

   

-

   

31

       

-

   

31

   

Adjusted EBITDA

 

$

34,507

 

$

32,955

 

4.7 %

 

$

103,295

 

$

96,592

 

6.9 %

 

Adjusted EBITDA Margin

   

18.7 %

   

17.4 %

       

18.7 %

   

17.5 %

   
                                   

Free operating cash flow:

                               

Net cash provided by operating activities - continuing operations, as reported

 

$

23,265

 

$

11,929

     

$

50,356

 

$

48,628

   

Less: Capital expenditures

   

(5,620)

   

(3,417)

       

(16,648)

   

(13,138)

   

Free cash flow from continuing operations

 

$

17,645

 

$

8,512

     

$

33,708

 

$

35,490

   
                                   

 

Standex International Corporation

Reconciliation of GAAP to Non-GAAP Financial Measures

(unaudited)

                                   
       

Three Months Ended

       

Nine Months Ended

   

Adjusted earnings per share from continuing operations

   

March 31,

       

March 31,

   
   

2023

   

2022

 

%
Change

   

2023

   

2022

 

% Change

                                   

Diluted earnings per share from continuing operations, as reported

 

$

6.77

 

$

1.44

 

370.1 %

 

$

9.98

 

$

3.98

 

150.8 %

                                   

Adjustments:

                               
 

Restructuring charges

   

0.14

   

0.07

       

0.21

   

0.16

   
 

Acquisition-related costs

   

-

   

0.03

       

0.03

   

0.10

   
 

Litigation (settlement refund) charge

   

(0.06)

   

-

       

(0.06)

   

0.10

   
 

(Gain) loss on sale of business

   

(5.22)

   

-

       

(5.22)

   

-

   
 

Environmental remediation

   

0.02

   

-

       

0.02

   

-

   
 

Discrete tax items

   

-

   

-

       

0.01

   

-

   

Diluted earnings per share from continuing operations, as adjusted

 

$

1.65

 

$

1.54

 

7.1 %

 

$

4.97

 

$

4.34

 

14.5 %

                                   

 

 

SOURCE Standex International Corporation

For further information: Christopher Howe, Director of Investor Relations, (773) 754-5394, e-mail: InvestorRelations@Standex.com
Sign up for Alerts